drugset / Trial / NCT00004284
Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria
Phase 3
Completed
300 enrolled
National Center for Research Resources (NCRR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collabUniversity of Texas · collab
RandomizedDouble-blindTreatment
Summary
OBJECTIVES: I. Evaluate the ability of a slow-releasing formulation of neutral potassium phosphate to correct hypercalciuria and prevent recurrent stone formation in patients with absorptive hypercalciuria. II. Evaluate the safety of this treatment. III. Compare the efficacy of potassium phosphate to that of potassium citrate.
Timeline
- Start
- 1995-04
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | POTASSIUM CITRATE ANHYDROUS | Small molecule | — | Oral |
| Subject | POTASSIUM PHOSPHATE, UNSPECIFIED FORM | Unknown | — | Oral |